Partner Content Partner Content Just two weeks to go until SMi’s flagship Pharmaceutical Mic... Just two weeks to go until Pharma Microbioloigy UK
Partner Content Partner Content Invite from Lynne Ensor chair for Pharma Microbiology East C... Invite from Lynne Ensor chair for Pharma Microbiology
Partner Content Partner Content Pharma Microbiology UK Conference to discuss Environmental M... Pharma Microbiology UK Conference to discuss EM
Partner Content Partner Content Registration Opens for SMi’s 3rd Annual Pharmaceutical Micro... Registration Opens SMi’s Pharma Microbiology Boston
Partner Content Partner Content Top decision makers to present at SMi’s 9th Annual Pharma Mi... Top decision makers to present at Pharma Microbiology
Partner Content Partner Content Co-Chairs invitation to SMi’s 9th Annual Pharmaceutical Micr... Co-Chairs invitation to SMi’s Pharma Microbiology
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.